AP Biosciences Inc (TPEX:6945)
Taiwan
· Delayed Price · Currency is TWD 51.80
-0.40 (-0.77%)
Apr 2, 2025, 2:52 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 4.40 billion as of April 2, 2025. Its market cap has increased by 7.58% in one year.
Market Cap
4.40B
Enterprise Value
2.74B
Revenue
32.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.80
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has decreased from 5.10B to 4.40B, a decrease of -13.61%. That is a compound annual growth rate of -8.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 4.44B | 5.05% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 172.52B |
| Caliway Biopharmaceuticals | 121.22B |
| Bora Pharmaceuticals Co., LTD. | 71.68B |
| Lotus Pharmaceutical | 58.91B |
| Oneness Biotech | 30.93B |
| Lumosa Therapeutics | 30.06B |
| Pegavision | 28.00B |
| Polaris Group | 27.65B |